Table 1.
Patient characteristics.
| n = 69 | |
|---|---|
| Sex | |
| Female | 55 (80.0) |
| Male | 14 (20.0) |
| Age, mean (SD) | 44.2 (11.9) |
| BMI kg/m2, median (IQR) | 24.2 (21.5, 26.7) |
| WHO classification | |
| Mild | 65 (94.2) |
| Moderate | 4 (5.8) |
| Days from first questionnaire to follow-up questionnaire, median (IQR) | 182 (174, 192) |
| Days from symptom onset to follow-up questionnaire, median (IQR) | 326 (300, 391) |
| Smoking history | |
| Current | 6 (8.7) |
| Former | 18 (26.1) |
| Never | 38 (55.2) |
| Ethnicity | |
| Caucasian | 58 (84) |
| Not Caucasian | 2 (3) |
| Missing data | 9 (13) |
| Marital status | |
| Living with a partner | 38 (55.1) |
| Living alone | 10 (14.5) |
| Missing data | 21 (30.4) |
| Reduced employment due to post-COVID-19 | 22 (31.9) |
| Reduced ≥ 50% | 10 (14.5) |
| Reduced < 50% | 12 (17.4) |
| Comorbidities | |
| Asthma | 9 (13.0) |
| Prepandemic mental health issues | 7 (10.1) |
| Other relevant comorbidities a | 14 (20.3) |
Values are n (%) unless otherwise stated. a Other relevant comorbidities were relevant cardiovascular disorders, rheumatological diseases and diseases of the thyroid.